ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment

Ghali J.R. , Bannister K.M. , Brown F.G. , Rosman J.B. , Wiggins K.J. , Johnson D.W. , McDonald S.P. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 2011; 31: 651–62.

Pérez Fontan M. , Rodríguez-Carmona A. , García-Naveiro R. , Rosales M. , Villaverde P. , Valdés F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25: 274–84.

Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int 2009; 29: 297–302.

Szeto C.C. , Wong T.Y. , Chow K.M. , Leung C.B. , Li P.K. Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 2003; 18: 977–82.

Brown M.C. , Simpson K. , Kerssens J.J. , Mactier R.A. Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007). Perit Dial Int 2011; 31: 639–50.

Boudville N. , Kemp A. , Clayton P. , Lim W. , Badve S.V. , Hawley C.M. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol 2012; 23: 1398–405.

Hsieh Y.P. , Chang C.C. , Wen Y.K. , Chiu P.F. , Yang Y. Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Taiwan—10 years’ experience in a single center. Perit Dial Int 2014; 34: 85–94.

Hsieh Y.P. , Chang C.C. , Wang S.C. , Wen Y.K. , Chiu P.F. , Yang Y. Predictors for and impact of high peritonitis rate in Taiwanese continuous ambulatory peritoneal dialysis patients. Int Urol Nephrol 2015; 47: 183–9.

Keane W.F. , Everett E.D. , Golper T.A. , Gokal R. , Halstenson C. , Kawaguchi Y. Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis. Perit Dial Int 1993; 13: 14–28.

Keane W.F. , Alexander S.R. , Bailie G.R. , Boeschoten E. , Gokal R. , Golper T.A. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16: 557–73.

Keane W.F. , Bailie G.R. , Boeschoten E. , Gokal R. , Golper T.A. , Holmes C.J. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000; 20: 396–411.

Piraino B. , Bailie G.R. , Bernardini J. , Boeschoten E. , Gupta A. , Holmes C. ; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107–31.

Li P.K. , Szeto C.C. , Piraino B. , Bernardini J. , Figueiredo A.E. , Gupta A. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010; 30: 393–423.

Piraino B. , Bernardini J. , Brown E. , Figueiredo A. , Johnson D.W. , Lye W.C. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 2011; 31: 614–30.

Atkins D. , Best D. , Briss P.A. , Eccles M. , Falck-Ytter Y. , Flottorp S. ; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490.

Warady B.A. , Bakkaloglu S. , Newland J. , Cantwell M. , Verrina E. , Neu A. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int 2012; 32(Suppl 2): S32–86.

Borg D. , Shetty A. , Williams D. , Faber M.D. Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program. Adv Perit Dial 2003; 19: 202–5.

Diaz-Buxo J.A. , Wick G.S. , Pesich A.A. Using CQI techniques for managing infections in PD patients. Nephrol News Issues 1998; 12: 22–4.

Cho Y. , Johnson D.W. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis 2014; 64: 278–89.

Piraino B. Today's approaches to prevent peritonitis. Contrib Nephrol 2012; 178: 246–50.

Kunin M. , Knecht A. , Holtzman E.J. Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review. Eur J Clin Microbiol Infect Dis 2014; 33: 1267–71.

Kavanagh D. , Prescott G.J. , Mactier R.A. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004; 19: 2584–91.

Kopriva-Altfahrt G. , König P. , Mündle M. , Prischl F. , Roob J.M. , Wiesholzer M. Exit-site care in Austrian peritoneal dialysis centers—a nationwide survey. Perit Dial Int 2009; 29: 330–9.

Han S.H. , Lee S.C. , Ahn S.V. , Lee J.E. , Choi H.Y. , Kim B.S. Improving outcome of CAPD: twenty-five years’ experience in a single Korean center. Perit Dial Int 2007; 27: 432–40.

Moraes T.P. , Pecoits-Filho R. , Ribeiro S.C. , Rigo M. , Silva M.M. , Teixeira P.S. Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Perit Dial Int 2009; 29: 492–8.

Rocha A. , Rodrigues A. , Teixeira L. , Carvalho M.J. , Mendonca D. , Cabrita A. Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis. Blood Purif 2012; 33: 284–91.

Fang W. , Ni Z. , Qian J. Key factors for a high-quality peritoneal dialysis program—the role of the PD team and continuous quality improvement. Perit Dial Int 2014; 34(Suppl 2): S35–42.

Nishina M. , Yanagi H. , Kakuta T. , Endoh M. , Fukagawa M. , Takagi A. A 10-year retrospective cohort study on the risk factors for peritoneal dialysis-related peritonitis: a single-center study at Tokai University Hospital. Clin Exp Nephrol 2014; 18: 649–54.

Schaefer F. , Kandert M. , Feneberg R. Methodological issues in assessing the incidence of peritoneal dialysis-associated peritonitis in children. Perit Dial Int 2002; 22: 234–8.

Pajek J. , Hutchison A.J. , Bhutani S. , Brenchley P.E. , Hurst H. , Perme M.P. Outcomes of peritoneal dialysis patients and switching to hemodialysis: a competing risks analysis. Perit Dial Int 2014; 34: 289–98.

van Diepen A.T. , Tomlinson G.A. , Jassal S.V. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol 2012; 7: 1266–71.

Figueiredo A. , Goh B. , Jenkins S. , Johnson D.W. , Mactier R. , Ramalakshmi S. Clinical practice guidelines for peritoneal access. Perit Dial Int 2010; 30: 424–9.

Wikdahl A.M. , Engman U. , Stegmayr B.G. , Sorenssen J.G. One-dose cefuroxime IV and IP reduces microbial growth in PD patients after catheter insertion. Nephrol Dial Transplant 1997; 12: 157–60.

Bennet-Jones D.N. , Martin J.B. , Barratt A.J. , Duffy T.J. , Naish P.F. , Aber G.M. Prophylactic gentamicin in the prevention of early exit-site infections and peritonitis in CAPD. Adv Perit Dial 1988; 4: 147–50.

Lye W.C. , Lee E.J. , Tan C.C. Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 1992; 26: 177–80.

Gadallah M.F. , Ramdeen G. , Mignone J. , Patel D. , Mitchell L. , Tatro S. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kidney Dis 2000; 36: 1014–9.

Strippoli G.F.M. , Tong A. , Johnson D. , Schena F.P. , Craig J.C. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 2004; 44: 591–603.

Gadallah M.F. , Pervez A. , el-Shahawy M.A. , Sorrells D. , Zibari G. , McDonald J. Peritoneoscopic versus surgical placement of peritoneal dialysis catheters: a prospective randomized study on outcome. Am J Kidney Dis 1999; 33: 118–22.

Tsimoyiannis E.C. , Siakas P. , Glantzounis G. , Toli C. , Sferopoulos G. , Pappas M. Laparoscopic placement of the Tenckhoff catheter for peritoneal dialysis. Surg Laparosc Endosc Percutan Tech 2000; 10: 218–21.

Wright M.J. , Bel'eed K. , Johnson B.F. , Eadington D.W. , Sellars L. , Farr M.J. Randomized prospective comparison of laparoscopic and open peritoneal dialysis catheter insertion. Perit Dial Int 1999; 19: 372–5.

Jwo S.C. , Chen K.S. , Lee C.C. , Chen H.Y. Prospective randomized study for comparison of open surgery with laparoscopic-assisted placement of Tenckhoff peritoneal dialysis catheter—a single center experience and literature review. J Surg Res 2010; 159: 489–96.

Strippoli G.F. , Tong A. , Johnson D. , Schena F.P. , Craig J.C. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol 2004; 15: 2735–46.

Ejlersen E. , Steven K. , Lokkegaard H. Paramedian versus midline incision for the insertion of permanent peritoneal dialysis catheters. A randomized clinical trial. Scand J Urol Nephrol 1990; 24: 151–4.

Rubin J. , Didlake R. , Raju S. , Hsu H. A prospective randomized evaluation of chronic peritoneal catheters. Insertion site and intraperitoneal segment. ASAIO Trans 1990; 36: M497–500.

Moncrief J.W. , Popovich R.P. , Dasgupta M. , Costerton J.W. , Simmons E. , Moncrief B. Reduction in peritonitis incidence in continuous ambulatory peritoneal dialysis with a new catheter and implantation technique. Perit Dial Int 1993; 13(Suppl 2): S329–31.

Park M.S. , Yim A.S. , Chung S.H. , Lee E.Y. , Cha M.K. , Kim J.H. Effect of prolonged subcutaneous implantation of peritoneal catheter on peritonitis rate during CAPD: a prospective randomized study. Blood Purif 1998; 16: 171–8.

Danielsson A. , Blohme L. , Tranaeus A. , Hylander B. A prospective randomized study of the effect of a subcutaneously ‘buried’ peritoneal dialysis catheter technique versus standard technique on the incidence of peritonitis and exit-site infection. Perit Dial Int 2002; 22: 211–9.

Twardowski Z.J. Presternal peritoneal catheter. Adv Ren Replace Ther 2002; 9: 125–32.

Akyol A.M. , Porteous C. , Brown M.W. A comparison of two types of catheters for continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990; 10: 63–6.

Eklund B.H. , Honkanen E.O. , Kala A.R. , Kyllonen L.E. Catheter configuration and outcome in patients on continuous ambulatory peritoneal dialysis: a prospective comparison of two catheters. Perit Dial Int 1994; 14: 70–4.

Eklund B.H. , Honkanen E.O. , Kala A.R. , Kyllonen L.E. Peritoneal dialysis access: prospective randomized comparison of the Swan neck and Tenckhoff catheters. Perit Dial Int 1995; 15: 353–6.

Lye W.C. , Kour N.W. , van der Straaten J.C. , Leong S.O. , Lee E.J. A prospective randomized comparison of the swan neck, coiled, and straight Tenckhoff catheters in patients on CAPD. Perit Dial Int 1996; 16(Suppl 1): S333–5.

Nielsen P.K. , Hemmingsen C. , Friis S.U. , Ladefoged J. , Olgaard K. Comparison of straight and curled Tenckhoff peritoneal dialysis catheters implanted by percutaneous technique: a prospective randomized study. Perit Dial Int 1995; 15: 18–21.

Scott P.D. , Bakran A. , Pearson R. , Riad H. , Parrott N. , Johnson R.W. , Gokal R. Peritoneal dialysis access. Prospective randomized trial of 3 different peritoneal catheters – preliminary report. Perit Dial Int 1994; 14: 289–90.

Johnson D.W. , Wong J. , Wiggins K.J. , Kirwan R. , Griffin A. , Preston J. A randomized controlled trial of coiled versus straight swan-neck Tenckhoff catheters in peritoneal dialysis patients. Am J Kidney Dis 2006; 48: 812–21.

Hagen S.M. , Lafranca J.A. , Ijzermans J.N. , Dor F.J. A systematic review and meta-analysis of the influence of peritoneal dialysis catheter type on complication rate and catheter survival. Kidney Int 2014; 85: 920–32.

Xie J.Y. , Chen N. , Ren H. , Huang X.M. , Zhu P. Prospective studies on applications of a two-cuff swan neck catheter and a Tenckhoff catheter to Chinese CAPD patients. Clin Nephrol 2009; 72: 373–9.

Li C.L. , Cui T.G. , Gan H.B. , Cheung K. , Lio W.I. , Kuok U.I. A randomized trial comparing conventional swan-neck straight-tip catheters to straight-tip catheters with an artificial subcutaneous swan neck. Perit Dial Int 2009; 29: 278–84.

USRDS. US Renal Data System Annual Data Report IV. Catheter-related factors and peritonitis risk in CAPD patients. Am J Kidney Dis 1992; 20(Suppl 2): 48–54.

Honda M. , Iitaka K. , Kawaguchi H. , Hoshii S. , Akashi S. , Kohsaka T. The Japanese National Registry data on pediatric CAPD patients: a ten-year experience. A report of the Study Group of Pediatric PD Conference. Perit Dial Int 1996; 16: 269–75.

Warady B.A. , Sullivan E.K. , Alexander S.R. Lessons from the peritoneal dialysis patient database: a report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int 1996; 53: S68–71.

Nessim S.J. , Bargman J.M. , Jassal S.V. Relationship between double-cuff versus single-cuff peritoneal dialysis catheters and risk of peritonitis. Nephrol Dial Transplant 2010; 25: 2310–14.

Eklund B. , Honkanen E. , Kyllonen L. , Salmella K. , Kala A.R. Peritoneal dialysis access: prospective randomized comparison of single-cuff and double-cuff straight Tenckhoff catheters. Nephrol Dial Transplant 1997; 12: 2664–6.

Lo W.K. , Lui S.L. , Li F.K. , Choy B.Y. , Lam M.F. , Tse K.C. A prospective randomized study on three different peritoneal dialysis catheters. Perit Dial Int 2003; 23(Suppl 2): S127–31.

Burkart J.M. , Hylander B. , Durnell-Figel T. , Roberts D. Comparison of peritonitis rates during long-term use of standard spike versus Ultraset in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990; 10: 41–3.

Maiorca R. , Cantaluppi A. , Cancarini G.C. , Scalamogna A. , Broccoli R. , Graziani G. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983; 2: 642–4.

Scalamogna A. , De Vecchi A. , Castelnovo C. , Guerra L. , Ponticelli C. Long-term incidence of peritonitis in CAPD patients treated by the Y-set technique: experience in a single center. Nephron 1990; 55: 24–7.

Harris D.C. , Yuill E.J. , Byth K. , Chapman J.R. , Hunt C. Twin- versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2392–8.

Kiernan L. , Kliger A. , Gorban-Brennan N. , Juergensen P. , Tesin D. , Vonesh E. Comparison of continuous ambulatory peritoneal dialysis-related infections with different ‘Y-tubing’ exchange systems. J Am Soc Nephrol 1995; 5: 1835–8.

Li P.K. , Szeto C.C. , Chau K.F. , Fung K.S. , Leung C.B. , Li C.S. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. Am J Kidney Dis 1999; 33: 535–40.

Monteon F. , Correa-Rotter R. , Paniagua R. , Amato D. , Hurtado M.E. , Medina J.L. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group. Kidney Int 1998; 54: 2123–8.

Cheng I.K. , Chan C.Y. , Cheng S.W. , Poon J.F. , Ji Y.L. , Lo W.K. A randomized prospective study of the cost-effectiveness of the conventional spike, O-set, and UVXD techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14: 255–60.

Canadian CAPD Clinical Trials Group Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y-connector disinfectant system to standard systems. Perit Dial Int 1989; 9: 159–63.

Dryden M.S. , McCann M. , Wing A.J. , Phillips I. Controlled trial of a Y-set dialysis delivery system to prevent peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Hosp Infect 1992; 20: 185–92.

Li P.K. , Chan T.H. , So W.Y. , Wang A.Y. , Leung C.B. , Lai K.N. Comparisons of Y-set disconnect system (Ultraset) versus conventional spike system in uremic patients on CAPD: outcome and cost analysis. Perit Dial Int 1996; 16(Suppl 1): S368–70.

Owen J.E. , Walker R.G. , Lemon J. , Brett L. , Mitrou D. , Becker G.J. Randomized study of peritonitis with conventional versus O-set techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 216–20.

Viglino G. , Colombo A. , Scalamogna A. , Cavalli P.L. , Guerra L. , Renzetti G. Prospected randomized study of two Y devices in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9: 165–8.

Viglino G. , Colombo A. , Cantu P. , Camerini C. , Catizone L. , Bonello F. In vitro and in vivo efficacy of a new connector device for continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2): S148–51.

Rottembourg J. , Brouard R. , Issad B. , Allouache M. , Jacobs C. Prospective randomized study about Y-connectors in CAPD patients. Adv Perit Dial 1987; 3: 107–13.

Lindholm T. , Simonsen O. , Krutzen L. Evaluation of a new take-off system (Ultraset) versus conventional spike system in uremic patients on CAPD: outcome and cost-analysis. Adv Perit Dial 1988; 4: 262–5.

Daly C. , Cody J.D. , Khan I. , Rabindranath K.S. , Vale L. , Wallace S.A. Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease. Cochrane Database Syst Rev 2014; 8: CD003078.

Daly C.D. , Campbell M.K. , MacLeod A.M. , Cody D.J. , Vale L.D. , Grant A.M. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001; 16: 341–7.

Piraino B. , Sheth H. Peritonitis—does peritoneal dialysis modality make a difference? Blood Purification 2010; 29: 145–9.

Mehrotra R. , Chiu Y.W. , Kalantar-Zadeh K. , Vonesh E. The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int 2009; 76: 97–107.

Rabindranath K.S. , Adams J. , Ali T.Z. , MacLeod A.M. , Vale L. , Cody J. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev 2007; 2: CD006515.

Rodriguez-Carmona A. , Perez Fontan M. , Garcia Falcon T. , Fernandez Rivera C. , Valdes F. A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis. Perit Dial Int 1999; 19: 253–8.

Bieber S.D. , Burkart J. , Golper T.A. , Teitelbaum I. , Mehrotra R. Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review. Am J Kidney Dis 2014; 63: 1027–37.

Akman S. , Bakkaloglu S.A. , Ekim M. , Sever L. , Noyan A. , Aksu N. Peritonitis rates and common microorganisms in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. Pediatr Int 2009; 51: 246–9.

Balasubramanian G. , McKitty K. , Fan S.L. Comparing automated peritoneal dialysis with continuous ambulatory peritoneal dialysis: survival and quality of life differences? Nephrol Dial Transplant 2011; 26: 1702–8.

Rüger W. , van Ittersum F.J. , Comazzetto L.F. , Hoeks S.E. , ter Wee P.M. Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitis. Perit Dial Int 2011; 31: 39–47.

Lan P.G. , Johnson D.W. , McDonald S.P. , Boudville N. , Borlace M. , Badve S.V. The association between peritoneal dialysis modality and peritonitis. Clin J Am Soc Nephrol 2014; 9: 1091–7.

Figueiredo A.E. , Bernardini J. , Bowes E. , Hiramatsu M. , Price V. , Su C. ISPD guideline / recommendations: a syllabus for teaching peritoneal dialysis to patients and caregivers. Perit Dial Int 2016. doi. 10.3747/pdi.2015.00277 (Epub ahead of print.]

Bernardini J. , Price V. , Figueiredo A. Peritoneal dialysis patient training, 2006. Perit Dial Int 2006; 26: 625–32.

Bender F.H. , Bernardini J. , Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl 2006: 103: S44–54.

Hall G. , Bogan A. , Dreis S. , Duffy A. , Greene S. , Kelley K. New directions in peritoneal dialysis patient training. Nephrol Nurs J 2004; 31: 149–63.

Holloway M. , Mujais S. , Kandert M. , Warady B.A. Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates. Perit Dial Int 2001; 21: 401–4.

Chow K.M. , Szeto C.C. , Law M.C. , Fung J.S. , Li P.K. Influence of peritoneal dialysis training nurses’ experience on peritonitis rates. Clin J Am Soc Nephrol 2007; 2: 647–52.

Russo R. , Manili L. , Tiraboschi G. , Amar K. , De Luca M. , Alberghini E. Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int Suppl 2006; 103: S127–32.

Ballerini L. , Paris V. Nosogogy: when the learner is a patient with chronic kidney failure. Kid Int 2006; 70: S122–6.

Arndt J. From compliance and false memory. J Exp Psych 2010; 36: 66–9.

Bordin G. , Cassati M. , Sicolo N. , Zuccherato N. , Eduati V. Patient education in peritoneal dialysis: an observational study in Italy. J Ren Care 2007; 33: 165–71.

Dong J. , Chen Y. Impact of the bag exchange procedure on risk of peritonitis. Perit Dial Int 2010; 30: 440–7.

Zhang L. , Hawley C.M. , Johnson D.W. Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrol Dial Transplant 2016; 31: 214–22.

Bernardini J. , Nagy M. , Piraino B. Pattern of noncompliance with dialysis exchanges in peritoneal dialysis patients. Am J Kidney Dis 2000; 35: 1104–10.

Bernardini J. , Dacko C. A survey of home visits at peritoneal dialysis centers in the United States. Perit Dial Int 1998; 18: 528–31.

Bernardini J. , Piraino B. Compliance in CAPD and CCPD patients as measured by supply inventories during home visits. Am J Kidney Dis 1998; 31: 101–7.

Ponferrada L. , Prowant B.F. , Schmidt L.M. , Burrows L.M. , Satalowich R.J. , Bartelt C. Home visit effectiveness for peritoneal dialysis patients. ANNA J 1993; 20: 333–6.

Kazancioglu R. , Ozturk S. , Ekiz S. , Yucel L. , Dogan S. Can using a questionnaire for assessment of home visits to peritoneal dialysis patients make a difference to the treatment outcome? J Ren Care 2008; 34: 59–63.

Nayak K.S. , Sinoj K.A. , Subhramanyam S.V. , Mary B. , Rao N.V. Our experience of home visits in city and rural areas. Perit Dial Int 2007; 27(Suppl 2): S27–31.

Ellis E.N. , Blaszak C. , Wright S. , Van Lierop A. Effectiveness of home visits to pediatric peritoneal dialysis patients. Perit Dial Int 2012; 32: 419–23.

Mawar S. , Gupta S. , Mahajan S. Non-compliance to the continuous ambulatory peritoneal dialysis procedure increases the risk of peritonitis. Int Urol Nephrol 2012; 44: 1243–9.

Ljungman S. Prevention of Peritonitis in Peritoneal Dialysis (PEPS). Available online at: https://clinicaltrials.gov/ct2/show/NCT01293799

Coles G.A. , O'Donoghue D.J. , Pritchard N. , Ogg C.S. , Jani F.M. , Gokal R. A controlled trial of two bicarbonate-containing dialysis fluids for CAPD—final report. Nephrol Dial Transplant 1998; 13: 3165–71.

Kim S. , Oh J. , Kim S. , Chung W. , Ahn C. , Kim S.G. , Oh K.H. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study. Nephrol Dial Transplant 2009; 24: 2899–908.

Bajo M.A. , Pérez-Lozano M.L. , Albar-Vizcaino P. , del Peso G. , Castro M.J. , Gonzalez-Mateo G. Low-GDP peritoneal dialysis fluid (‘balance’) has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. Nephrol Dial Transplant 2011; 26: 282–91.

Rippe B. , Simonsen O. , Heimbürger O. , Christensson A. , Haraldsson B. , Stelin G. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59: 348–57.

Johnson D.W. , Brown F.G. , Clarke M. , Boudville N. , Elias T.J. , Foo M.W. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial. Perit Dial Int 2012; 32: 497–506.

Fan S.L. , Pile T. , Punzalan S. , Raftery M.J. , Yaqoob M.M. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int 2008; 73: 200–6.

Srivastava S. , Hildebrand S. , Fan S.L. Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival. Kidney Int 2011; 80: 986–91.

Cho Y. , Badve S.V. , Hawley C.M. , McDonald S.P. , Brown F.G. , Boudville N. Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes. Clin J Am Soc Nephrol 2013; 8: 1556–63.

Johnson D.W. , Brown F.G. , Clarke M. , Boudville N. , Elias T.J. , Foo M.W. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol 2012; 23: 1097–107.

Cho Y. , Johnson D.W. , Badve S.V. , Craig J.C. , Strippoli G.F. , Wiggins K.J. The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int 2013; 84: 969–79.

Strippoli G.F. , Tong A. , Johnson D. , Schena F.P. , Craig J.C. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2004; 4: CD004679.

Tacconelli E. , Carmeli Y. , Aizer A. , Ferreira G. , Foreman M.G. , D'Agata E.M. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37: 1629–38.

Bernardini J. , Piraino B. , Holley J. , Johnston J.R. , Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695–700.

Chu K.H. , Choy W.Y. , Cheung C.C. , Fung K.S. , Tang H.L. , Lee W. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections. Perit Dial Int 2008; 28: 505–8.

Xu G. , Tu W. , Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2010; 25: 587–92.

Luzar M.A. , Brown C.B. , Balf D. , Hill L. , Issad B. , Monnier B. Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial. Perit Dial Int 1990; 10: 25–9.

Mahajan S. , Tiwari S.C. , Kalra V. , Bhowmik D.M. , Agarwal S.K. , Dash S.C. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population. Perit Dial Int 2005; 25: 473–7.

Lim C.T. , Wong K.S. , Foo M.W. The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital. Nephrol Dial Transplant 2005; 20: 2202–6.

Davenport A. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit. J Nephrol 2012; 25: 819–24.

Wong C. , Luk I.W. , Ip M. , You J.H. Prevention of gram-positive infections in peritoneal dialysis patients in Hong Kong: a cost-effectiveness analysis. Am J Infect Control 2014; 42: 412–6.

Aykut S. , Caner C. , Ozkan G. , Ali C. , Tugba A. , Zeynep G. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience. Ren Fail 2010; 32: 356–61.

Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol 1996; 7: 2403–8.

Piraino B. Mupirocin for preventing peritonitis and exit site infections in patients undergoing peritoneal dialysis. Was it effective? Nephrol Dial Transplant 2010; 25: 349–52.

Chua A.N. , Goldstein S.L. , Bell D. , Brewer E.D. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin J Am Soc Nephrol 2009; 4: 1939–43.

Lobbedeez T. , Gardam M. , Dedier H. , Burdzy D. , Chu M. , Izatt S. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 2004; 19: 3140–3.

Perez-Fontan M. , Rosales M. , Rodriguez-Carmona A. , Falcon T.G. , Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002; 39: 337–41.

Annigeri R. , Conly J. , Vas S. , Dedier H. , Prakashan K.P. , Bargman J.M. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21: 554–9.

Al-Hwiesh A.K. , Abdul-Rahman I.S. , Al-Muhanna F.A. , Al-Sulaiman M.H. , Al-Jondebi M.S. , Divino-Filho J.C. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance. Int J Artif Organs 2013; 36: 473–83.

Piraino B. , Bernardini J. , Florio T. , Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 2003; 23: 456–9.

Mahaldar A. , Weisz M. , Kathuria P. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis. Adv Perit Dial 2009; 25: 56–9.

Pierce D.A. , Williamson J.C. , Mauck V.S. , Russell G.B. , Palavecino E. , Burkart J.M. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int 2012; 32: 525–30.

Lo M.W. , Mak S.K. , Wong Y.Y. , Lo K.C. , Chan S.F. , Tong G.M. Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream. Perit Dial Int 2013; 33: 267–72.

Johnson D.W. , Badve S.V. , Pascoe E.M. , Beller E. , Cass A. , Clark C. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. Lancet Infect Dis 2014; 14: 23–30.

McQuillan R.F. , Chiu E. , Nessim S. , Lok C.E. , Roscoe J.M. , Tam P. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study. Clin J Am Soc Nephrol 2012; 7: 297–303.

Montenegro J. , Saracho R. , Aguirre R. , Martinez I. , Iribar I. , Ocharan J. Exit-site care with ciprofloxacin otologic solution prevents polyurethane catheter infection in peritoneal dialysis patients. Perit Dial Int 2000; 20: 209–14.

Zimmerman S.W. , Ahrens E. , Johnson C.A. , Craig W. , Leggett J. , O'Brien M. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991; 18: 225–31.

Blowey D.L. , Warady B.A. , McFarland K.S. The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients. Adv Perit Dial 1994; 10: 297–99.

Falagas M.E. , Fragoulis K.N. , Bliziotis I.A. Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure—a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2006; 21: 2536–42.

Churchill D.N. , Taylor D.W. , Vas S.I. Peritonitis in continuous ambulatory peritoneal dialysis patients: a randomized clinical trial of cotrimoxazole prophylaxis. Perit Dial Int 1988; 8: 125–8.

Low D.E. , Vas S.I. , Oreopoulos D.G. , Manuel M.A. , Saiphoo M.M. , Finer C. Prophylactic cephalexin ineffective in chronic ambulatory peritoneal dialysis. Lancet 1980; 2: 753–4.

Sesso R. , Parisio K. , Dalboni A. , Rabelo T. , Barbosa D. , Cendoroglo M. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1994; 41: 370–6.

van Diepen A.T. , Jassal S.V. A qualitative systematic review of the literature supporting a causal relationship between exit-site infection and subsequent peritonitis in patients with end-stage renal disease treated with peritoneal dialysis. Perit Dial Int 2013; 33: 604–10.

Lloyd A. , Tangri N. , Shafer L.A. , Rigatto C. , Perl J. , Komenda P. The risk of peritonitis after an exit site infection: a time-matched, case-control study. Nephrol Dial Transplant 2013; 28: 1915–21.

Fried L. , Bernardini J. , Johnston J.R. , Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2176–82.

Yip T. , Tse K.C. , Lam M.J. , Cheng S.W. , Lui S.L. , Tang S. Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int 2007; 27: 560–4.

Machuca E. , Ortiz A.M. , Rabagliata R. Streptococcus viridian-associated peritonitis after gastroscopy. Adv Perit Dial 2005; 21: 60–2.

Poortvliet W. , Selten H.P. , Raasveld M.H. , Klemt-Kropp M. CAPD peritonitis after colonoscopy: follow the guidelines. Neth J Med 2010; 68: 377–8.

Holley J.L. , Udekwu A. , Rault R. , Piraino B. The risks of laparoscopic cholecystectomy in CAPD compared with hemodialysis patients: a study often patients. Perit Dial Int 1994; 14(Suppl 1): S27–9.

Wu H.H. , Li I.J. , Weng C.H. , Lee C.C. , Chen Y.C. , Chang M.Y. Prophylactic antibiotics for endoscopy-associated peritonitis in peritoneal dialysis patients. PLOS ONE 2013; 8: e71532.

Singharetnam W. , Holley J.L. Acute treatment of constipation may lead to transmural migration of bacteria resulting in gram-negative, polymicrobial, or fungal peritonitis. Perit Dial Int 1996; 16: 423–5.

Wood C.F. , Fleming V. , Tunridge J. , Thomson N. , Atkins R.C. Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kidney Dis 1992; 19: 257–63.

Su C.Y. , Pei J. , Lu X.H. , Tang W. , Wang T. Gastrointestinal symptoms predict peritonitis rates in CAPD patients. Clin Nephrol 2012; 77: 267–74.

Chuan Y.W. , Shu K.H. , Yu T.M. , Cheng C.H. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 2009; 24: 1603–8.

Szeto C.C. , Kwan B.C. , Chow K.M. , Law M.C. , Pang W.F. , Chung K.Y. Recurrent and relapsing peritonitis: causative organisms and response to treatment. Am J Kidney Dis 2009; 54: 702–10.

Shu K.H. , Chang C.S. , Chuang Y.W. , Chen C.H. , Cheng C.H. , Wu M.J. Intestinal bacterial overgrowth in CAPD patients with hypokalaemia. Nephrol Dial Transplant 2009; 24: 1289–92.

Chuang Y.W. , Shu K.H. , Yu T.M. , Cheng C.H. , Chen C.H. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 2009; 24: 1603–8.

Afsar B. , Elsurer R. , Bilgic A. , Sezer S. , Ozdemir F. Regular lactulose use is associated with lower peritonitis rates: an observational study. Perit Dial Int 2010; 30: 243–6.

Li P.K. , Leung C.B. , Leung A.K. , Luk W.K. , Lai K.N. Posthysteroscopy fungal peritonitis in a patient on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 21: 446–8.

Ceri M. , Altay M. , Unverdi S. , Kurultak I. , Duranay M. An unusual presentation of vaginal leakage in a peritoneal dialysis patient. Perit Dial Int 2010; 30: 663–5.

Cobelo C. , Ros S. , Trujillo C. , Garcia P. An unusual case of vaginal leak in a patient on peritoneal dialysis. Perit Dial Int 2010; 30: 665–6.

Neumann J.L. , Moran J. Peritonitis due to a peritoneal vaginal fistula. Nephrol Nurs J 2010; 37: 177–8.

Yildiz N. , Turhan P. , Biglic O. , Erguven M. , Candan C. Vaginal dialysate leak in a child on peritoneal dialysis. Perit Dial Int 2010; 30: 666–7.

Shukla A. , Abreu Z. , Bargman J.M. Streptococcal PD peritonitis—a 10-year review of one centre's experience. Nephrol Dial Transplant 2006; 21: 3545–9.

Levy M. , Balfe J.W. , Geary D. , Fryer-Keene S.P. Factors predisposing and contributing to peritonitis during chronic peritoneal dialysis in children: a ten-year experience. Perit Dial Int 1990; 10: 263–9.

Prasad N. , Gupta A. , Sharma R.K. , Sinha A. , Kumar R. Impact of nutritional status on peritonitis in CAPD patients. Perit Dial Int 2007; 27: 42–7.

Wang W. , Bernardini J. , Piraino B. , Fried L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis 2003; 41: 664–9.

Troidel L. , Watnick S. , Wuerth D.B. , Gorban-Brennan N. , Kliger A.S. , Finkelstein F.O. Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 2003; 42: 350–4.

Paudel K. , Namagondlu G. , Samad N. , McKitty K. , Fan S.L. Lack of motivation: a new modifiable risk factor for peritonitis in patients undergoing peritoneal dialysis? J Ren Care 2015; 41: 33–42.

Satomura A. , Yanai M. , Fujita T. , Arashima Y. , Kumasaka K. , Nakane C. Paterurella multocida: molecular evidence of zoonotic etiology. Ther Apher Dial 2010; 14: 373–6.

Broughton A. , Verger C. , Goffin E. Pets-related peritonitis in peritoneal dialysis: companion animals or Trojan horses? Semin Dial 2010; 23: 306–16.

Rudnicki M. , Kerschbaum J. , Hausdorfer J. , Mayer G. , Konig P. Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin D. Perit Dial Int 2010; 30: 541–8.

Kerschbaum J. , Vychytil A. , Lhotta K. , Prischl F.C. , Wiesholzer M. , Machhold-Fabrizii V. Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis. PLOS ONE 2013; 8: e67836.

Wang J. , Zhang H. , Liu J. , Zhang K. , Yi B. , Liu Y. Implementation of a continuous quality improvement program reduces the occurrence of peritonitis in PD. Ren Fail 2014; 36: 1029–32.

Qamar M. , Sheth H. , Bender F.H. , Piraino B. Clinical outcomes in peritoneal dialysis: impact of continuous quality improvement initiatives. Adv Perit Dial 2009; 25: 76–9.

Prasad K.N. , Prasad N. , Gupta A. , Sharma R.K. , Verma A.K. , Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 2004; 48: 96–101.

Wang A.Y. , Yu A.W. , Li P.K. , Lam P.K. , Leung C.B. , Lai K.N. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36: 1183–92.

Goldie S.J. , Kiernan-Troidle L. , Torres C. , Gorban-Brennan N. , Dunne D. , Kliger A.S. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28: 86–91.

Zaruba K. , Peters J. , Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years’ experience. Am J Kidney Dis 1991; 17: 43–6.

Robitaille P. , Merouani A. , Clermont M.J. , Hebert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 1995; 15: 77–9.

Lo W.K. , Chan C.Y. , Cheng S.W. , Poon J.F. , Chan D.T. , Cheng I.K. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 549–52.

Wong P.N. , Lo K.Y. , Tong G.M. , Chan S.F. , Lo M.W. , Mak S.K. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 2007; 27: 531–6.

Thodis E. , Vas S.I. , Bargman J.M. , Singhal M. , Chu M. , Oreopoulos D.G. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis (see Comment). Perit Dial Int 1998; 18: 583–9.

Williams P.F. , Moncrieff N. , Marriott J. No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20: 352–3.

Wadhwa N.K. , Suh H. , Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial 1996; 12: 189–91.

Restrepo C. , Chacon J. , Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int 2010; 30: 619–25.

Davenport A. , Wellsted D. Does antifungal prophylaxis with daily oral fluconazole reduce the risk of fungal peritonitis in peritoneal dialysis patients? The Pan Thames Renal Audit. Blood Purif 2011; 32: 181–5.

Lopes K. , Rocha A. , Rodrigues A. , Carvalho M.J. , Cabrita A. Long-term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis. Int J Artif Organs 2013; 36: 484–8.

Kumar K.V. , Mallikarjuna H.M. , Gokulnath , Jayanthi S. Fungal peritonitis in continuous ambulatory peritoneal dialysis: The impact of antifungal prophylaxis on patient and technique outcomes. Indian J Nephrol 2014; 24: 297–301.

Finkelstein E.S. , Jekel J. , Troidle L. , Gorban-Brennan N. , Finkelstein F.O. , Bia F.J. Patterns of infection inpatients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002; 39: 1278–86.

Piraino B. Peritoneal dialysis catheter replacement: save the patient and not the catheter. Sem Dial 2003; 16: 72–5.

Ballinger A.E. , Palmer S.C. , Wiggins K.J. , Craig J.C. , Johnson D.W. , Cross N.B. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev 2014; 4: CD005284.

Cancarini G.C. , Manili L. , Brunori G. , Camerini C. , Zubani R. , Colombrita D. Simultaneous catheter replacement/removal during infectious complications in peritoneal dialysis. Adv Perit Dial 1994; 10: 210–3.

Lui S.L. , Yip T. , Tse K.C. , Lam M.F. , Lai K.N. , Lo W.K. Treatment of refractory Pseudomonas aeruginosa exit-site infection by simultaneous removal and reinsertion of peritoneal dialysis catheter. Perit Dial Int 2005; 25: 560–3.

Rocklin M.A. , Teitelbaum I. Noninfectious causes of cloudy peritoneal dialysate. Semin Dial 2001; 14: 37–40.

Gould I.M. , Casewell M.W. The laboratory diagnosis of peritonitis during continuous ambulatory peritoneal dialysis. J Hosp Infect 1986; 7: 155–60.

Flanigan M.J. , Freeman R.M. , Lim V.S. Cellular response to peritonitis among peritoneal dialysis patients. Am J Kidney Dis 1985; 6: 420–4.

Lee C.C. , Sun C.Y. , Chang K.C. , Wu M.S. Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis. Ther Apher Dial 2010; 14: 201–8.

Alfa M.J. , Degagne P. , Olson N. , Harding G.K. Improved detection of bacterial growth in continuous ambulatory peritoneal dialysis effluent by use of BacT/Alert FAN bottles. J Clin Microbiol 1997; 35: 862–6.

Azap O.K. , Timurkaynak F. , Sezer S. , Cağir U. , Yapar G. , Arslan H. Value of automatized blood culture systems in the diagnosis of continuous ambulatory peritoneal dialysis peritonitis. Transplant Proc 2006; 38: 411–2.

Sewell D.L. , Golper T.A. , Hulman P.B. , Thomas C.M. , West L.M. , Kubey W.Y. Comparison of large volume culture to other methods for isolation of microorganisms from dialysate. Perit Dial Int 1990; 10: 49–52.

Chow K.M. , Chow V.C. , Szeto C.C. , Law M.C. , Leung C.B. , Li P.K. Continuous ambulatory peritoneal dialysis peritonitis: broth inoculation culture versus water lysis method. Nephron Clin Pract 2007; 105(3): c121–5.

Iyer R.N. , Reddy A.K. , Gande S. , Aiyangar A. Evaluation of different culture methods for the diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin Microbiol Infect 2014; 20: 0294–6.

Park S.J. , Lee J.Y. , Tak W.T. , Lee J.H. Using reagent strips for rapid diagnosis of peritonitis in peritoneal dialysis patients. Adv Perit Dial 2005; 21: 69–71.

Akman S. , Uygun V. , Guven A.G. Value of the urine strip test in the early diagnosis of bacterial peritonitis. Pediatr Int 2005; 47: 523–7.

Nguyen-Khac E. , Cadranel J.F. , Thevenot T. , Nousbaum J.B. Review article: The utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients. Aliment Pharmacol Ther 2008; 28: 282–8.

Yoo T.H. , Chang K.H. , Ryu D.R. , Kim J.S. , Choi H.Y. , Park H.C. Usefulness of 23S rRNA amplification by PCR in the detection of bacteria in CAPD peritonitis. Am J Nephrol 2006; 26: 115–20.

Johnson G. , Wilks M. , Warwick S. , Millar M.R. , Fan S.L. Comparative study of diagnosis of PD peritonitis by quantitative polymerase chain reaction for bacterial DNA vs culture methods. J Nephrol 2006; 19: 45–9.

Ro Y. , Hamada C. , Io H. , Hayashi K. , Hirahara I. , Tomino Y. Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit. J Clin Lab Anal 2004; 18: 224–30.

Ota K. , Maruyama H. , Iino N. , Nakamura G. , Shimotori M. , Tanabe Y. Rapid detection of causative pathogen of peritonitis using in-situ hybridization in a patient with continuous ambulatory peritoneal dialysis. J Infect Chemother 2007; 13: 273–5.

Kim S.H. , Jeong H.S. , Kim Y.H. , Song S.A. , Lee J.Y. , Oh S.H. Evaluation of DNA extraction methods and their clinical application for direct detection of causative bacteria in continuous ambulatory peritoneal dialysis culture fluids from patients with peritonitis by using broad-range PCR. Ann Lab Med 2012; 32: 119–25.

Chang Y.T. , Wang H.C. , Wang M.C. , Wu A.B. , Sung J.M. , Sun H.S. Rapid identification of bacteria and Candida pathogens in peritoneal dialysis effluent from patients with peritoneal dialysis-related peritonitis by use of multilocus PCR coupled with electrospray ionization mass spectrometry. J Clin Microbiol 2014; 52: 1217–9.

Ahmadi S.H. , Neela V. , Hamat R.A. , Goh B.L. , Syafinaz A.N. Rapid detection and identification of pathogens in patients with continuous ambulatory peritoneal dialysis (CAPD) associated peritonitis by 16s rRNA gene sequencing. Trop Biomed 2013; 30: 602–7.

Lin C.Y. , Roberts G.W. , Kift-Morgan A. , Donovan K.L. , Topley N. , Eberl M. Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients. J Am Soc Nephrol 2013; 24: 2002–9.

Bieber S.D. , Anderson A.E. , Mehrotra R. Diagnostic testing for peritonitis in patients undergoing peritoneal dialysis. Semin Dial 2014; 27: 602–6.

Barretti P. , Doles J.V. , Pinotti D.G. , El Dib R. Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: a proportional meta-analysis. BMC Infect Dis 2014; 14: 445.

Flanigan M.J. , Lim V.S. Initial treatment of dialysis associated peritonitis: A controlled trial of vancomycin versus cefazolin. Perit Dial Int 1991; 11: 31–7.

Lupo A. , Rugiu C. , Bernich P. , Laudon A. , Marcantoni C. , Mosconi G. A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: teicoplanin plus tobramycin versus cephalothin plus tobramycin. J Antimicrob Chemother 1997; 40: 729–32.

Khairullah Q. , Provenzano R. , Tayeb J. , Ahmad A. , Balakrishnan R. , Morrison L. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients. Perit Dial Int 2002; 22: 339–44.

Gucek A. , Bren A.F. , Hergouth V. , Lindic J. Cefazolin and netilmicin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis. Adv Perit Dial 1997; 13: 218–20.

Zelenitsky S. , Barns L. , Findlay I. , Alfa M. , Ariano R. , Fine A. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36: 1009–13.

Lui S.L. , Cheng S.W. , Ng F. , Ng S.Y. , Wan K.M. , Yip T. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 2005; 68: 2375–80.

Wong K.M. , Chan Y.H. , Cheung C.Y. , Chak W.L. , Choi K.S. , Leung S.H. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis associated peritonitis. Am J Kidney Dis 2001; 38: 127–31.

Kobayashi K. , Nakamoto H. , Okada S. , Hoshitani K. , Uchida K. , Arima H. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 2006; 22: 65–8.

Leung C.B. , Szeto C.C. , Chow K.M. , Kwan B.C. , Wang A.Y. , Lui S.F. Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis—a randomized controlled trial. Perit Dial Int 2004; 24: 440–6.

Goffin E. , Herbiet L. , Pouthier D. , Pochet J.M. , Lafontaine J.J. , Christophe J.L. Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis. Perit Dial Int 2004; 24: 433–9.

Lima R.C. , Barreira A. , Cardoso F.L. , Lima M.H. , Leite M. Jr. Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up. Perit Dial Int 2007; 27: 56–60.

Cheng I.K. , Fang G.X. , Chau P.Y. , Chan T.M. , Tong K.L. , Wong A.K. A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD. Perit Dial Int 1998; 18: 371–5.

Lye W.C. , Lee E.J. , van der Straaten J. Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis. Perit Dial Int 1993; 13(Suppl 2): S348–50.

Chan M.K. , Cheng I.K. , Ng W.S. A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1990; 15: 155–9.

Fuiano G. , Sepe V. , Viscione M. , Nani E. , Conte G. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9: 273–5.

Gerig J.S. , Bolton N.D. , Swabb E.A. , Scheld W.M. , Bolton W.K. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics. Kidney Int 1984; 26: 308–18.

Anwar N. , Merchant M. , Were T. , Tooth A. , Uttley L. , Gokal R. A prospective, randomized study of the comparative safety and efficacy of intraperitoneal imipenem versus vancomycin and netilmicin in the treatment of peritonitis on CAPD. Perit Dial Int 1995; 15: 167–71.

Baker R.J. , Senior H. , Clemenger M. , Brown E.A. Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 2003; 41: 670–5.

Szeto C.C. , Kwan B.C. , Chow K.M. , Chung S. , Yu V. , Cheng P.M. Predictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 2015; 35: 180–8.

Badve S.V. , Hawley C.M. , McDonald S.P. , Brown F.G. , Boudville N.C. , Wiggins K.J. Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function. Nephrol Dial Transplant 2012; 27: 381–7.

Altmann P. , Butter K. , Cunningham J. , Drew P. , Goodwin F. , Marsh F. CAPD peritonitis: 10 or 21 days treatment? Kidney Int 1984; 26: 544.

Tokgoz B. , Somdas M.A. , Ucar C. , Kocyigit I. , Unal A. , Sipahioglu M.H. Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD. Ren Fail 2010; 32: 179–84.

Wiggins K.J. , Craig J.C. , Johnson D.W. , Strippoli G.F. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev 2008; 1: CD005284.

Fontán M.P. , Cambre H.D. , Rodríguez-Carmona A. , Muñiz A.L. , Falcón T.G. Treatment of peritoneal dialysis-related peritonitis with ciprofloxacin monotherapy: clinical outcomes and bacterial susceptibility over two decades. Perit Dial Int 2009; 29: 310–8.

Celik A. , Cirit M. , Tünger A. , Akçiçek F. , Basçi A. Treatment of CAPD peritonitis with oral trimethoprim/sulfamethoxazole and intraperitoneal aminoglycoside combination. Perit Dial Int 1999; 19: 284–5.

Lam M.F. , Tang B.S. , Tse K.C. , Chan T.M. , Lai K.N. Ampicillin-sulbactam and amikacin used as second-line antibiotics for patients with culture-negative peritonitis. Perit Dial Int 2008; 28: 540–2.

Tosukhowong T. , Eiam-Ong S. , Thamutok K. , Wittayalertpanya S. , Na Ayudhya D. P. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2001; 21: 587–94.

de Paepe M. , Lameire N. , Belpaire F. , Bogaert M. Peritoneal pharmacokinetics of gentamicin in man. Clin Nephrol 1983; 19: 107–9.

Lye W.C. , Wong P.L. , van der Straaten J.C. , Leong S.O. , Lee E.J. A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis. Adv Perit Dial 1995; 11: 179–81.

Neale T.J. , Malani J. , Humble M. Netilmicin in the treatment of clinical peritonitis in chronic renal failure patients managed by continuous ambulatory peritoneal dialysis. N Z Med J 1987; 100: 374–7.

Bunke C.M. , Aronoff G.R. , Brier M.E. , Sloan R.S. , Luft F.C. Tobramycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983; 34: 110–6.

Bunke C.M. , Aronoff G.R. , Luft F.C. Pharmacokinetics of common antibiotics used in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1983; 3: 114–7.

Manley H.J. , Bailie G.R. , Frye R. , Hess L.D. , McGoldrick M.D. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis. J Am Soc Nephrol 2000; 11: 1310–6.

Manley H.J. , Bailie G.R. , Asher R.D. , Eisele G. , Frye R.F. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19: 65–70.

Yuen S.K. , Yuen Y.P. , Fok S.P. , Yong S.P. , Tse M.W. , Chan A.Y. A novel intraperitoneal cefepime regime based on pharmacokinetic modeling to treat CAPD peritonitis. Perit Dial Int 2010; 30: 660–1.

Li P.K. , Ip M. , Law M.C. , Szeto C.C. , Leung C.B. , Wong T.Y. Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis. Perit Dial Int 2000; 20: 232–4.

Leehey D.J. , Reid R. , Chan A.Y. , Ing T.S. Cefoperazone in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients. Artif Organs 1988; 12: 482–3.

Hodler J.E. , Galeazzi R.L. , Frey B. , Rudhardt M. , Seiler A.J. Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications. Eur J Clin Pharmacol 1984; 26: 609–12.

Albin H.C. , Demotes-Mainard F.M. , Bouchet J.L. , Vincon G.A. , Martin-Dupont C. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis. Clin Pharmacol Ther 1985; 38: 285–9.

Booranalertpaisarn V. , Eiam-Ong S. , Wittayalertpanya S. , Kanjanabutr T. , Na Ayudhya D.P. Pharmacokinetics of ceftazidime in CAPD-related peritonitis. Perit Dial Int 2003; 23: 574–9.

Grabe D.W. , Bailie G.R. , Eisele G. , Frye R.F. Pharmacokinetics of intermittent intraperitoneal ceftazidime. Am J Kidney Dis 1999; 33: 111–7.

Albin H. , Ragnaud J.M. , Demotes-Mainard F. , Vinçon G. , Couzineau M. , Wone C. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis. Eur J Clin Pharmacol 1986; 31: 479–83.

Bulger R.J. , Bennett J.V. , Boen S.T. Intraperitoneal administration of broad-spectrum antibiotics in patients with renal failure. JAMA 1965; 194: 1198–1202.

Bierhoff M. , Krutwagen E. , van Bommel E.F. , Verburgh C.A. Listeria peritonitis in patients on peritoneal dialysis: two cases and a review of the literature. Neth J Med 2011; 69: 461–4.

Lunde N.M. , Messana J.M. , Swartz R.D. Unusual causes of peritonitis in patients undergoing continuous peritoneal dialysis with emphasis on Listeria monocytogenes. J Am Soc Nephrol 1992; 3: 1092–7.

Ahmad M. , Krishnan A. , Kelman E. , Allen V. , Bargman J.M. Listeria monocytogenes peritonitis in a patient on peritoneal dialysis: a case report and review of the literature. Int Urol Nephrol 2008; 40: 815–9.

Blackwell B.G. , Leggett J.E. , Johnson C.A. , Zimmerman S.W. , Craig W.A. Ampicillin and sulbactam pharmacokinetics and pharmacodynamics in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990; 10: 221–6.

Zaidenstein R. , Weissgarten J. , Dishi V. , Koren M. , Soback S. , Gips M. Pharmacokinetics of intraperitoneal piperacillin/tazobactam in patients on peritoneal dialysis with and without pseudomonas peritonitis. Perit Dial Int 2000; 20: 227–31.

Cheng I.K. , Chan C.Y. , Wong W.T. , Cheng S.W. , Ritchie C.W. , Cheung W.C. A randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2): S351–4.

Chang M.J. , Namgung H. , Choi H.D. , Song Y.R. , Kim S.G. , Oh J.M. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study. Basic Clin Pharmacol Toxicol 2012; 110: 504–9.

Huen S.C. , Hall I. , Topal J. , Mahnensmith R.L. , Brewster U.C. , Abu-Alfa A.K. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis. Am J Kidney Dis 2009; 54: 538–41.

Cheng I.K. , Lui S.L. , Fang G.X. , Chau P.Y. , Cheng S.W. , Chiu F.H. A randomized prospective comparison of oral versus intraperitoneal ofloxacin as the primary treatment of CAPD peritonitis. Nephrology (Carlton) 1997; 3: 431–5.

Fitzpatrick M.A. , Esterly J.S. , Postelnick M.J. , Sutton S.H. Successful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal polymyxin B and ampicillin-sulbactam. Ann Pharmacother 2012; 46: e17.

Lynn W.A. , Clutterbuck E. , Want S. , Markides V. , Lacey S. , Rogers T.R. Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin / dalfopristin. Lancet 1994; 344: 1025–6.

Vlaar P.J. , van Hulst M. , Benne C.A. , Janssen W.M. Intraperitoneal compared with intravenous meropenem for peritoneal dialysis-related peritonitis. Perit Dial Int 2013; 33: 708–9.

Liakopoulos V. , Leivaditis K. , Nikitidou O. , Divani M. , Antoniadi G. , Dombros N. Intermittent intraperitoneal dose of teicoplanin in peritoneal dialysis-related peritonitis. Perit Dial Int 2012; 32: 365–6.

Fish R. , Nipah R. , Jones C. , Finney H. , Fan S.L. Intraperitoneal vancomycin concentrations during peritoneal dialysis-associated peritonitis: correlation with serum levels. Perit Dial Int 2012; 32: 332–8.

Bunke C.M. , Aronoff G.R. , Brier M.E. , Sloan R.S. , Luft F.C. Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983; 34: 631–7.

Dahl N.V. , Foote E.F. , Searson K.M. , Fein J.L. , Kapoian T. , Steward C.A. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis. Ann Pharmacother 1998; 32: 1284–9.

Roberts D.M. , Kauter G. , Ray J.E. , Gillin A.G. Intraperitoneal voriconazole in a patient with Aspergillus peritoneal dialysis peritonitis. Perit Dial Int 2013; 33: 92–3.

Koomanachai P. , Landersdorfer C.B. , Chen G. , Lee H.J. , Jitmuang A. , Wasuwattakul S. Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 2014; 58: 440–6.

Cardone K.E. , Grabe D.W. , Kulawy R.W. , Daoui R. , Roglieri J. , Meola S. Ertapenem pharmacokinetics and pharmacodynamics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 2012; 56: 725–30.

DePestel D.D. , Peloquin C.A. , Carver P.L. Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis. Pharmacotherapy 2003; 23: 1322–6.

Song I.J. , Seo J.W. , Kwon Y.E. , Kim Y.L. , Lim T.S. , Kang E.W. Successful treatment of vancomycin-resistant enterococcus peritonitis using linezolid without catheter removal in a peritoneal dialysis patient. Perit Dial Int 2014; 34: 235–9.

Yang J.W. , Kim Y.S. , Choi S.O. , Han B.G. Successful use of intravenous linezolid in CAPD patient with vancomycin-resistant enterococcal peritonitis. Perit Dial Int 2011; 31: 209–10.

Skalioti C. , Tsaganos T. , Stamatiadis D. , Giamarellos-Bourboulis E.J. , Boletis J. , Kanellakopoulou K. Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 2009; 29: 575–9.

Zimmerman S.W. , Ahrens E. , Johnson C.A. , Craig W. , Leggett J. , O'Brien M. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991; 18: 225–31.

Blowey D.L. , Warady B.A. , McFarland K.S. The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients. Adv Perit Dial 1994; 10: 297–9.

Wong P.N. , Lo K.Y. , Tong G.M. , Chan S.F. , Lo M.W. , Mak S.K. Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine, and delayed catheter replacement in continuous ambulatory peritoneal dialysis. Perit Dial Int 2008; 28: 155–62.

Madariaga M.G. , Tenorio A. , Proia L. Trichosporon inkin peritonitis treated with caspofungin. J Clin Microbiol 2003; 41: 5827–9.

Fourtounas C. , Marangos M. , Kalliakmani P. , Savidaki E. , Goumenos D.S. , Vlachojannis J.G. Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy. Nephrol Dial Transplant 2006; 21: 236–7.

Chan T.M. , Chan C.Y. , Cheng S.W. , Lo W.K. , Lo C.Y. , Cheng I.K. Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. Nephrol Dial Transplant 1994; 9: 539–42.

Sedlacek M. , Cotter J.G. , Suriawinata A.A. , Kaneko T.M. , Zuckerman R.A. , Parsonnet J. Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B. Am J Kidney Dis 2008; 51: 302–6.

Ghebremedhin B. , Bluemel A. , Neumann K.H. , Koenig B. , Koenig W. Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole. J Med Microbiol 2009; 58: 678–82.